Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-003686
- form_type
- 8-K
- ticker
- DFNS
- cik
- 0001787518
- company_name
- T3 Defense Inc.
- filed_at
- 2026-01-13T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.180597+00:00
- generated_at
- 2026-05-16T10:41:43.662518+00:00
- sec_items
- ["1.01", "2.01", "3.02", "7.01", "9.01"]
- event_type
- m_and_a
- sentiment
- positive
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-003686
- json_url
- https://secwatch.observer/filing/0001213900-26-003686.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-003686.md
- text_url
- https://secwatch.observer/filing/0001213900-26-003686.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1787518/000121390026003686/0001213900-26-003686-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1787518/000121390026003686/ea0272508-8k_nukkleus.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
OCFC
OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus
OCEANFIRST FINANCIAL CORP
June 1, 2026, 5:19 PM ET
m_and_a
Items 1.01, 3.02, 2.01, 2.03, 3.03, 5.02, 5.03, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
of Flushing (“ Flushing Common Stock ”) issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, was converted into the right to receive 0.85 of a share (the “ Exchange Ratio ”) of common stock, par value $0.01 per share, of OceanFirst (“ OceanFirst Common Stock ” and such consideration, the “ Merger Consideration ”).
Filing page
SEC filing
APAD
Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M
Enhanced Group Inc.
May 8, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
On May 7, 2026, as contemplated by the Business Combination Agreement and as described in the section titled “ The BCA Proposal ” beginning on pa ge 180 of the Proxy Statement/Prospectus, the Company, Enhanced and Merger Sub consummated the business combination contemplated by the Business Combination Agreement, whereby: • Merger Sub merged with and into Enhanced (the “First Merger”), with Enhanced surviving the merger as a wholly owned subsidiary of the Company;
Filing page
SEC filing
RMIX
Suncrete acquires Nelson Bros. Ready Mix for $42.3M cash + stock; earnout up to $18M
Suncrete, Inc.
May 7, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
Mr. Owens, Ms. Owens and JAO, the “Sellers”),
and Jacob Owens in his capacity as representative of the Sellers. The aggregate consideration
for the Acquisition consisted of (i) 1,296,456 shares of Class A Common Stock, par value $0.0001 per share, of the Company (“Class
A Common Stock”) issued to the Sellers (the “Stock Consideration”) and (ii) a $42.3 million net
Filing page
SEC filing
GYRE
Gyre Therapeutics completes $300M all-stock acquisition of Cullgen; appoints Ying Luo as CEO
GYRE THERAPEUTICS, INC.
May 4, 2026, 7:59 PM ET
m_and_a
Items 2.01, 5.03, 1.01, 3.02, 3.03, 5.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
Revenue Code of 1986, as
amended. Under the terms of the Merger Agreement, the Company acquired Cullgen in an all-stock transaction that valued Cullgen at
approximately $300 million. At the effective time of the Merger (the “Effective Time”), each then outstanding share of Cullgen capital stock (the “Cullgen Capital Stock”), excluding shares of Cullgen
Filing page
SEC filing
BKKT
Bakkt completes acquisition of DTR; issues ~11.3M shares to sellers including CEO
Bakkt, Inc.
April 30, 2026, 7:59 PM ET
m_and_a
Items 2.01, 1.01, 3.02, 5.01, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
Purchase Agreement) for purposes of consummating the acquisition of DTR at Closing. At the closing of the acquisition of DTR (the “Closing”), the Company issued an aggregate of 11,316,775 shares (such shares, the “Consideration Shares”) of its Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”), comprised of (A) 31.5% of (i) the aggregate
Filing page
SEC filing
RMIX
Suncrete completes acquisition of Hope Concrete (10 plants, 88 trucks) for $39.4M + equity
Suncrete, Inc.
April 29, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
in its capacity as representative of the Sellers. After giving effect to the
transactions contemplated by the Purchase Agreement, the aggregate consideration consisted of (i) 220,007 shares (the “Mikytuck
Rollover Securities”) of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”)
issued to Mr. Mikytuck, (ii) 69,511
Filing page
SEC filing
LSF
Laird Superfood acquires Terrasoul for $48M cash plus $5M earnout; Nexus invests $60M in preferred stock
Laird Superfood, Inc.
April 21, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 5.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
Interests (as defined in the Terrasoul Acquisition Agreement) which constitute all of the issued and outstanding equity interests of Terrasoul, for a purchase price of (i) $48.0 million in cash, subject to customary purchase price adjustments, including adjustments for working capital, cash, debt and transaction expenses and (ii) potential earnout consideration
Filing page
SEC filing
PHGE
BiomX accelerates option exercise, acquires 60% stake in DFSL for $750k cash, $3M note
BiomX Inc.
April 13, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 7.01, 9.01
same fact type: ma_transaction
same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01
same event type: m_and_a
similar materiality
This filing
On January 12, 2026, Nukkleus Inc., a Delaware corporation (the “Company”), completed its acquisition of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc., a Nevada corporation (“Star 26”), pursuant to the terms of that certain Amended and Restated Securities Purchase Agreement and Call Option, dated September 15, 2025 (the “Purchase Agreement”), by and among the Company, Star 26, the shareholders of Star 26 (the “Sellers”), and Menachem Shalom, as representative of the Sellers.
Comparable filing
delivery. In consideration for the Purchased Shares, the
Company agreed to the following consideration to Mandragola: (i) a cash payment of Seven Hundred Fifty Thousand Dollars ($750,000),
of which Four Hundred Fifty Thousand ($450,000) was advanced by the Company; (ii) the issuance of an unsecured convertible promissory note in the principal
amount of Three
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.